Frances A. Collichio

9.5k total citations · 2 hit papers
100 papers, 4.6k citations indexed

About

Frances A. Collichio is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Frances A. Collichio has authored 100 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 27 papers in Molecular Biology and 26 papers in Genetics. Recurrent topics in Frances A. Collichio's work include CAR-T cell therapy research (40 papers), Virus-based gene therapy research (26 papers) and Immunotherapy and Immune Responses (18 papers). Frances A. Collichio is often cited by papers focused on CAR-T cell therapy research (40 papers), Virus-based gene therapy research (26 papers) and Immunotherapy and Immune Responses (18 papers). Frances A. Collichio collaborates with scholars based in United States, Germany and United Kingdom. Frances A. Collichio's co-authors include David W. Ollila, Elizabeth Claire Dees, Lisa A. Carey, Mark L. Graham, Dominic T. Moore, Lynda Sawyer, Carolyn I. Sartor, Charles M. Perou, Robert H.I. Andtbacka and Igor Puzanov and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Frances A. Collichio

94 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

2007 1.6k citations Lisa A. Carey, Elizabeth Claire Dees et al. profile →
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma

2017 471 citations Frances A. Collichio, Omid Hamid et al. Journal of Clinical Oncology profile →

Peers

Frances A. Collichio

ONCOL

GENET

IMMUN

David S.P. Tan Singapore

Susana Banerjee United Kingdom

Tamar Safra Israel

Paul DiSilvestro United States

Hiroko Yamashita Japan

Mansoor Raza Mirza Denmark

Federica Tomao Italy

Stephen A. Cannistra United States

Stanley B. Kaye United Kingdom

Hellmut Samonigg Austria

David S.P. Tan Singapore

Frances A. Collichio

2.5k ×0.8

ONCOL

2.2k ×1.6

1.5k ×1.1

664 ×0.6

GENET

504 ×0.6

IMMUN

Citations per year, relative to Frances A. Collichio Frances A. Collichio (= 1×) peers David S.P. Tan

Countries citing papers authored by Frances A. Collichio

Since Specialization

Citations

This map shows the geographic impact of Frances A. Collichio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances A. Collichio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances A. Collichio more than expected).

Fields of papers citing papers by Frances A. Collichio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frances A. Collichio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances A. Collichio. The network helps show where Frances A. Collichio may publish in the future.

Co-authorship network of co-authors of Frances A. Collichio

This figure shows the co-authorship network connecting the top 25 collaborators of Frances A. Collichio. A scholar is included among the top collaborators of Frances A. Collichio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frances A. Collichio. Frances A. Collichio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vincent, Benjamin G., Karen P. McKinnon, Jeffrey A. Frelinger, et al.. (2023). Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors. The Journal of Immunology. 211(2). 219–228. 11 indexed citations

Gibson, Keisha L., et al.. (2023). Seeking Racial Equity in Hematology and Oncology: a Fellow-Led Educational Series to Promote Reflection and Action. Journal of Cancer Education. 38(4). 1241–1244. 2 indexed citations

Karachaliou, Georgia Sofia, Rached Alkallas, Nirali M. Patel, et al.. (2022). The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma. BMC Cancer. 22(1). 38–38. 5 indexed citations

Bischof, Jason J., et al.. (2021). A hybrid model of acute unscheduled cancer care provided by a hospital-based acute care clinic and the emergency department: a descriptive study. Supportive Care in Cancer. 29(12). 7479–7485. 6 indexed citations

Hanson, Laura C., Kathryn L. Wessell, Feng‐Chang Lin, et al.. (2021). Pre-Post Evaluation of Collaborative Oncology Palliative Care for Patients With Stage IV Cancer. Journal of Pain and Symptom Management. 62(3). e56–e64. 1 indexed citations

Haydon, Andrew, Muhammad Alamgeer, Daniel Brungs, et al.. (2021). 1094TiP A randomized, controlled, open-label, phase II study of cemiplimab as a single agent and in combination with RP1 in patients with advanced cutaneous squamous cell carcinoma [CERPASS]. Annals of Oncology. 32. S904–S904. 2 indexed citations

Hanson, Laura C., Natalie C. Ernecoff, Kathryn L. Wessell, et al.. (2020). Mortality Risk for Patients With Stage IV Cancer and Acute Illness Hospitalization. Journal of Pain and Symptom Management. 61(4). 797–804. 5 indexed citations

Naqash, Abdul Rafeh, et al.. (2019). Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series. Journal for ImmunoTherapy of Cancer. 7(1). 4–4. 17 indexed citations

Hanson, Laura C., Frances A. Collichio, Stephen A. Bernard, et al.. (2017). Integrating Palliative and Oncology Care for Patients with Advanced Cancer: A Quality Improvement Intervention. Journal of Palliative Medicine. 20(12). 1366–1371. 28 indexed citations

10.

D’Angelo, Sandra P., Omid Hamid, Ahmad A. Tarhini, et al.. (2017). A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma. Investigational New Drugs. 36(1). 103–113. 21 indexed citations

11.

Kaidar‐Person, Orit, Timothy M. Zagar, Allison M. Deal, et al.. (2017). The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases. Anti-Cancer Drugs. 28(6). 669–675. 57 indexed citations

12.

Andtbacka, Robert Hans Ingemar, Howard L. Kaufman, Kevin J. Harrington, et al.. (2016). Timing of onset and resolution of adverse events in patients with unresectable stage IIIB-IVM1a melanoma treated with talimogene laherparepvec (T-VEC) in OPTiM. Melanoma Research. 26. 1 indexed citations

13.

Franceschi, Ana M., Stergios J. Moschos, Carey K. Anders, et al.. (2016). Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma. Journal of Computer Assisted Tomography. 40(5). 803–805. 24 indexed citations

14.

Shanafelt, Tait D., Marilyn Raymond, Leora Horn, et al.. (2014). Oncology Fellows' Career Plans, Expectations, and Well-Being: Do Fellows Know What They Are Getting Into?. Journal of Clinical Oncology. 32(27). 2991–2997. 46 indexed citations

15.

Collichio, Frances A., et al.. (2013). Historical review of melanoma treatment and outcomes. Clinics in Dermatology. 31(2). 141–147. 65 indexed citations

16.

Kimple, Randall J., et al.. (2010). Concurrent Temozolomide and Radiation, a Reasonable Option for Elderly Patients With Glioblastoma Multiforme?. American Journal of Clinical Oncology. 33(3). 265–270. 34 indexed citations

17.

Stinchcombe, Thomas E., Mark A. Socinski, Christine M. Walko, et al.. (2007). Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors. Cancer Chemotherapy and Pharmacology. 60(5). 759–766. 65 indexed citations

18.

Dees, Elizabeth Claire, Karen P. McKinnon, Jennifer J. Kuhns, et al.. (2004). Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer. Cancer Immunology Immunotherapy. 53(9). 777–785. 29 indexed citations

19.

Collichio, Frances A., et al.. (2002). Phase II Study of Low-Dose Infusional 5-Fluorouracil and Paclitaxel (Taxol) Given Every 2 Weeks in Metastatic Breast Cancer. American Journal of Clinical Oncology. 25(2). 194–197. 6 indexed citations

20.

Collichio, Frances A., Paul D. Woolf, & Martin Brower. (1994). Management of patients with small cell carcinoma and the syndrome of ectopic corticotropin secretion. Cancer. 73(5). 1361–1367. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact